Afuco™ Anti-Human MFI2 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-MFI2 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies target melanotransferrin, a glycosylphosphatidylinositol-anchored glycoprotein first identified as p97, a cell-surface marker in melanomas.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-504CL |
| Pricing | Inquiry |
| Host | Human |
| Target | MFI2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4°C or -20°C, avoid repeated freezing and thawing. |